Christoph Lengauer, Thrive co-founder (Third Rock Ventures)

Third Rock-backed star­tup's blood test can sniff out can­cer in pa­tients with no his­to­ry of dis­ease

The myr­i­ad of liq­uid biop­sy com­pa­nies work­ing on blood tests for ear­ly can­cer de­tec­tion have been con­duct­ing ret­ro­spec­tive stud­ies, look­ing at how ef­fec­tive and sen­si­tive …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.